Levetiracetam's unique mechanism of action distinguishes it from most other antiepileptics. It acts by:

• A Blocking AMPA receptors on postsynaptic neurons
• B Potentiating GABA-A receptor function via the benzodiazepine site
• C Binding to synaptic vesicle glycoprotein 2A (SV2A), modulating vesicular neurotransmitter release ✓
• D Inhibiting carbonic anhydrase in glial cells

Explanation

Levetiracetam has a novel, highly specific mechanism: it binds to synaptic vesicle protein SV2A, which is involved in the regulation of synaptic vesicle exocytosis. This interaction reduces the release of excitatory neurotransmitters during high-frequency bursting. Its lack of interaction with sodium channels, GABA receptors, or calcium channels explains its distinct pharmacological profile and limited drug interactions.

Reference: KD Tripathi, Essentials of Medical Pharmacology, 8th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.